Skip to Content
Morningstar

ARK Israel Innovative Technology ETF IZRL

Morningstar Medalist Rating
Medalist Rating as of | See ARK Investment Hub

Morningstar’s Analysis IZRL

Will IZRL outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable IZRL’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the IZRL management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of IZRL’s parent organization’s priorities and whether they’re in line with investors’ interests.

Despite People Pillar weakness and an Average Process Pillar, ARK Israel Innovative Technology ETF gets enough right to retain its Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IZRL

More IZRL Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 21.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cash

2.21 2.2 Mil
Cash and Equivalents

Cellebrite DI Ltd

2.20 2.2 Mil
Technology

Check Point Software Technologies Ltd

2.14 2.1 Mil
Technology

Monday.Com Ltd Ordinary Shares

2.10 2.1 Mil
Technology

Magic Software Enterprises Ltd

2.10 2.1 Mil
Technology

Ituran Location and Control Ltd

2.10 2.1 Mil
Technology

Radware Ltd

2.10 2.1 Mil
Technology

Tower Semiconductor Ltd

2.09 2.1 Mil
Technology

Danel (Adir Yeoshua) Ltd

2.08 2.1 Mil
Healthcare

Teva Pharmaceutical Industries Ltd ADR

2.08 2.1 Mil
Healthcare